Gerwin Heller
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 14
- Cancer-related gene regulation 7
- RNA modifications and cancer 7
- Oncology 22
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Sabine Zöchbauer‐Müller (22 shared papers)Christoph Zielinski (16 shared papers)Barbara Ziegler (11 shared papers)Leonhard Müllauer (12 shared papers)Veronika Sexl (14 shared papers)Erwin Tomasich (22 shared papers)György Láng (7 shared papers)Adelheid End‐Pfützenreuter (7 shared papers)
- Journals
- Blood (7 papers)Cancer Research (4 papers)Oncogene (3 papers)Oncotarget (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Gerwin Heller
75 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 432
- Hematology 243
- Oncology 522
- Molecular Biology 1.1k
- Immunology 313
Countries citing papers authored by Gerwin Heller
This map shows the geographic impact of Gerwin Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerwin Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerwin Heller more than expected).
Fields of papers citing papers by Gerwin Heller
This network shows the impact of papers produced by Gerwin Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerwin Heller. The network helps show where Gerwin Heller may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerwin Heller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 177 | |
| 2 | 2008 | 141 | |
| 3 | 2012 | 140 | |
| 4 | 2016 | 130 | |
| 5 | 2017 | 113 | |
| 6 | 2017 | 105 | |
| 7 | 2010 | 91 | |
| 8 | 2014 | 77 | |
| 9 | 2007 | 75 | |
| 10 | 2005 | 69 | |
| 11 | 2013 | 67 | |
| 12 | 2007 | 59 | |
| 13 | 2016 | 47 | |
| 14 | 2006 | 44 | |
| 15 | 2005 | 39 | |
| 16 | 2019 | 38 | |
| 17 | 2021 | 37 | |
| 18 | 2012 | 31 | |
| 19 | 2018 | 30 | |
| 20 | 2020 | 29 |
About Gerwin Heller
Gerwin Heller is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Genetics, having authored 79 papers that have together received 2.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (14 papers), Acute Myeloid Leukemia Research (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (8 papers), Cancer-related gene regulation (7 papers), RNA modifications and cancer (7 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Cancer Research (432 citations), Hematology (243 citations), Oncology (522 citations), Molecular Biology (1.1k citations) and Immunology (313 citations). Gerwin Heller has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Sabine Zöchbauer‐Müller, Christoph Zielinski, Barbara Ziegler, Leonhard Müllauer, Veronika Sexl, Erwin Tomasich, György Láng, Adelheid End‐Pfützenreuter, Karoline Kollmann and Matthias Preusser. Their work appears in journals such as Blood, Cancer Research, Oncogene, Oncotarget and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.